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Background/aim: A novel complex of a nutritional supplement (CDB) contains chromium picolinate (CrPic), phosphatidylserine (PS),
docosahexaenoic acid (DHA), and boron (B). The present study aimed to investigate the effects of CDB on the metabolic profile and
memory acquisition in rats fed a high-fat diet (HFD).
Materials and methods: Male Wistar rats were divided into six groups and received either a regular diet or HFD supplemented with or
without different levels of CDB (0, 11, or 22 mg/kg BW).
Results: Rats fed the HFD had greater glucose, insulin, lipid profile, and serum malondialdehyde concentrations, but lower serotonin
and tryptophan in the serum and brain and lower Cr concentrations in serum, kidney, brain, and liver (P < 0.0001). CDB complex
supplementation reversed all the effects, and the reversal effect was more pronounced with HFD for some parameters. Latency was less
(P < 0.05) but probe was greater (P < 0.0001) for rats fed a regular diet. Increasing CDB complex levels in the diets resulted in a linear
decrease in latency (P < 0.0002) but a linear increase in probe (P < 0.0002).
Conclusion: Findings of the present work indicate that the CDB complex could be considered as an alternative treatment for preventing
certain metabolic diseases and improving neurological functions, such as learning and memory.
Key words: Chromium picolinate, docosahexaenoic acid, boron, high-fat diet

1. Introduction
Diet is a determining factor in maintaining metabolic,
neural, and cognitive balance for humans (1). Consuming
a high-fat diet (HFD) for an extended period, for example,
results in obesity, metabolic disorders, and oxidative stress
in humans (2,3) as well as in rats (4). Rats fed a HFD
have also been reported to have decreased brain function
expressed as learning and memory deficits (5,6). It has been
shown that feeding a diet rich in fat decreased hippocampal
neurogenesis in rats (7). Studies also indicated that HFDs
significantly increased weight gain and insulin resistance,
resulting in impaired glucose tolerance in rats (8), and
increased triglycerides and cholesterol concentrations in
other animals (9).
Chromium (Cr) is an essential trace element for
mammals. Chromium picolinate (CrPic) supplementation
has been reported to improve glucose utilization by neural
cells (10) and to reduce hepatic and serum thiobarbituric
acid reactive substance (TBARS) formation in rats (5). Kim
et al. (11) found that CrPic in Cr-deficient rats leads to the
* Correspondence: nsahinkm@yahoo.com
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improvement of glucose intolerance, insulin sensitivity, and
weight loss and also an improvement in lipid metabolism.
Clinical studies suggested that oral supplementation of
phosphatidylserine (PS) and docosahexaenoic acid (DHA)
resulted in a little therapeutic effect in improving memory
and other cognitive functions in elderly individuals with
memory complaints (12), but improvement of lipid (13)
and carbohydrate metabolism (14) as well as reduced
reactive oxygen species in mice (15).
The dietary need for and effects of boron (B)
supplementation in humans and animals have not been
fully illuminated. Some studies reported the inconsistent
effects of boron on insulin, energy substrates (triglycerides,
glucose), and oxidative metabolism (16–18). Assessments
in both animals and humans have shown that boron
deprivation results in decreased brain electrical activity
(19).
The aim of this study was to test whether a complex
(CDB) containing CrPic, PS, DHA, and B is effective
on live weight, serum glucose, insulin, total cholesterol,
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triglyceride concentrations, tissue and blood Cr
content, serotonin, tryptophan, oxidative balance
(malondialdehyde, MDA), as well as to evaluate the
neuroprotective effect by determining learning and
memory performances in rats fed a HFD. The CDB
complex was greatly effective in reducing body weight,
blood glucose, cholesterol, triglyceride, and oxidative
stress and in improving memory in rats fed a HFD.
2. Materials and methods
2.1. Animals and diets
Male Wistar rats (n = 60, 8 weeks old) weighing 180 ± 10
g were purchased from the Veterinary Research Institute
(Elazığ, Turkey). The animals were housed at a temperature
of 22 ± 2 °C, humidity of 55 ± 5%, and light/dark cycle of
12/12 h throughout the experiment. All animal procedures
were approved by the Institutional Animal Care and Use
Committee at the Institute of Veterinary Research (Elazığ,
Turkey). All procedures involving rats were conducted
in strict compliance with relevant laws, the Animal
Welfare Act, public health services policy, and guidelines
established by the Institutional Animal Care and Use
Committee of the institute. Rats were fed a regular diet
(12% of calories from fat) or a HFD (42% of calories
from fat). The compositions of the control and high-fat
diets are given in Table 1. The CDB complex, containing
Table 1. Composition of diets (g/kg diet) fed to rats.
Control

HFD*

Casein

200.0

200.0

Starch

579.5

150.0

Sucrose

50.0

149.5

Soybean oil

70.0

-

Beef tallow

-

400.0

Cellulose

50.0

50.0

Vitamin-mineral premix**

45.0

45.0

l-cysteine

3.0

3.0

Choline Bitartrate

2.5

2.5

*: HFD: High-fat diet; **:The vitamin-mineral premix provides
the following (per kg): all-trans-retinyl acetate, 1.8 mg;
cholecalciferol, 0.025 mg; all-rac-a-tocopherol acetate, 12.5 mg;
menadione (menadione sodium bisulfate), 1.1 mg; riboflavin,
4.4 mg; thiamine (thiamine mononitrate), 1.1 mg; vitamin B6,
2.2 mg; niacin, 35 mg; Ca-pantothenate, 10 mg; vitamin B12,
0.02 mg; folic acid, 0.55 mg; d-biotin, 0.1 mg; manganese (from
manganese oxide), 40 mg; iron (from iron sulfate), 12.5 mg; zinc
(from zinc oxide), 25 mg; copper (from copper sulfate), 3.5 mg;
iodine (from potassium iodide), 0.3 mg; selenium (from sodium
selenite), 0.15 mg; choline chloride, 175 mg.

CrPic (14 µg elemental Cr) as Chromax®, PS (4.5 mg),
DHA (6 mg), and B (14 µg), was provided by Nutrition
21 (Purchase, NY, USA). The supplemental complex (total
~11 mg) was given to rats at a dose per kilogram body
weight (BW) per day. The supplements were dissolved in
ethanol (with the final ethanol concentration being 0.01%)
before administration. Supplementation (11 mg or 22 mg/
kg BW) was administered via orally inserted intragastric
intubation once a day at 0900 hours. Control rats received
isovolumetric intragastric intubation of drinking water
containing the ethanol (concentration being 0.01%) at the
same time. The experiment lasted for 12 weeks.
2.2. Experimental design
A total of 60 male rats were divided into 6 groups of 10
animals each in 2 × 3 factorial designs (2 diets and 3
levels of CDB complex). The experimental diets fed to rats
were as follows: i) control group: rats were fed a standard
diet (12% calories from fat, 3.82 kcal/g); ii) 11 mg CDB
complex group: rats were fed the standard diet and received
11 mg of CDB complex; iii) 22 mg CDB complex group:
rats were fed a standard diet and received 22 mg of CDB
complex; iv) HFD group: rats were fed a high-fat diet (42%
calories from fat, 4.70 kcal/g); v) HFD group plus 11 mg
CDB complex: rats were fed a high-fat diet and received
11 mg of CDB complex; vi) HFD group plus 22 mg CDB
complex: rats were fed a high-fat diet and received 22 mg
of CDB complex. Diets and fresh water were offered ad
libitum throughout the experiment. The diets were stored
at 4 °C in a dark room.
2.3. Data collection and laboratory analyses
At the end of the experiment, all rats were sacrificed by
cervical dislocation. Blood samples were taken and the
liver, kidneys, and brain were removed and processed for
biochemical and western blot analyses. Blood samples were
centrifuged at 3000 × g for 10 min and sera were separated.
Serum glucose (ACCU-Check Active, Roche Diagnostics,
Mannheim, Germany) and insulin (Linco Research Inc, St.
Charles, MO, USA) concentrations were measured using a
commercial kit in a spectrophotometer with ELISA (ELx800, Bio-Tek Instruments Inc., Winooski, VT). Serum total
cholesterol (TC) and triglyceride (TG) concentrations
were also determined using an autoanalyzer (Samsung
LABGEO PT10, Samsung Electronics Co., Suwon, Korea).
Composite of Insulin Sensitivity Index (CISI) scores were
calculated according to the following formula (20):
CISI = 10,000/square root of [(G0) (I0) (mean serum
insulin during OGTT) (mean blood glucose during
OGTT)].
After digestion with a mixture of concentrated HNO3
(65%, Merck, Darmstadt, Germany) and H2O2 (30%,
Merck) in a microwave digestion system (Berghoff,
Eningen, Germany), liver, kidney, and brain samples and
blood sera were analyzed for Cr content using a graphite
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furnace atomic absorption spectrophotometer (AAnalyst
800, PerkinElmer Corp., Norwalk, CT, USA) as described
by Dogukan et al. (21).
Serum MDA concentrations were measured by highperformance liquid chromatography (HPLC; Shimadzu,
Tokyo, Japan) using a Shimadzu UV-Vis with a SPD-10
AVP detector and a CTO-10 AS VP column. The mobile
phase was 30 mM KH2PO4-methanol (82.5 + 17.5, v/v
%, pH: 3.6) and the flow rate was 1.2 mL/min. Column
effluents were monitored at 250 nm and the injection
volume was 20 µL. The serum MDA level was measured
(22) using the fully automatic HPLC (Shimadzu, Kyoto,
Japan).
Brain samples upon killing were rapidly removed and
dissected on ice, wrapped in foil, and immediately frozen
and stored at –80 °C until the serotonin concentration
and binding assay could be performed. Brain samples
were homogenized in 0.1 N HCl (100 µL/mg of tissue)
and centrifuged for 10 min at 1500 × g at 4 °C. From
this extract, serotonin levels were measured using
enzyme-linked immunosorbent assay kits (IBL ImmunoBiological Lab., Hamburg, Germany) according to
the manufacturer’s protocol. Brain insulin levels were
measured as mentioned previously by Havrankova et
al. (23). Serum and brain tryptophan was measured
using HPLC (Shimadzu, Tokyo, Japan). Separation was
obtained with a reverse-phase column and a mobile
phase (flow rate: 1 mL/min) composed of 5% acetonitrile,
100 mM phosphate buffer (pH 3.6), and 1 mM
ethylenediaminetetraacetic acid (EDTA). Detection was
done with a Shimadzu model LC 120 (HPLC; Shimadzu,
Tokyo, Japan). Excitation and emission wavelengths were
313 and 420 nm, respectively.
On five consecutive days at the end of the experiment,
animals were subjected to a spatial version of the
Morris water maze test to evaluate their spatial memory
acquisition phase (SMAP) performance (24). In this
test, time to reach the platform (latency in seconds) was
measured after placing the black target platform inside the
pool 1 cm above the water line as described by Baydas et
al. (25). To attain the extent of the memory consolidation
after learning, rats were subjected to a probe trial in which
a visible platform was placed on a new location on the
final day of training (26). In this test, mean percentage
time spent in the target quadrant reflects the degree of
memory consolidation.
2.4. Statistical analysis
The data were analyzed using the general linear model
procedure of SAS software for a factorial design.
Significant differences at 5% among treatment means
were determined for all groups. When F-tests were
significant, orthogonal contrasts were used to determine
linear and quadratic effects of increasing CDB level.
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3. Results
Effects of HFD and CDB complex level on body weight
and various biochemical parameters are presented in
Table 2. Body weights were lower for rats fed the control
diet than for rats fed the HFD (276.8 vs. 306.7 g; P <
0.0001). CDB complex level did not affect BW (Table 2).
Serum glucose and insulin concentrations and the ratio
of glucose to insulin were all lower (P < 0.0001) for rats
fed the control diet than for rats fed the HFD (Table 2).
Increasing CDB complex level resulted in both decreased
serum glucose concentrations and ratio of glucose to
insulin but increased serum insulin concentrations (Table
2; linear, P < 0.0001). Significant dietary calorie level
by CDB complex level interaction effect revealed that
serum glucose concentrations decreased whereas serum
insulin and the ratio of glucose to insulin concentrations
increased at a lesser extent in the control rats than the
HFD rats as CDB complex level increased (Table 2; P ≤
0.05). Insulin resistance during of this study in rats was
assessed by CISI score (Table 2). CISI score was greater for
rats fed the control diet than for rats fed the HFD, further
showing improved insulin sensitivity (P < 0.0001). The
CDB complex level linearly increased the CISI score (P <
0.0001). Significant dietary calorie level by CDB complex
level interaction effect revealed that CISI scores increased
to a lesser extent in the control rats than the HFD rats as
CDB complex level increased (Table 2; P < 0.0001).
All serum TC, TG, and FFA concentrations were lower
for rats fed the control diet than for rats fed the HFD (P
< 0.0001). CDB complex levels linearly decreased serum
TC, TG, and FFA concentrations (P < 0.0001). Significant
dietary calorie level by CDB level interaction effect revealed
that serum TC, TG, and FFA concentrations decreased to a
lesser extent in the control rats than the HFD rats as CDB
complex level increased (Table 2; P < 0.0001).
Serum MDA concentrations were lower in rats fed
the control diet than in rats fed the HFD (P < 0.0001).
Supplementing CDB to the diet of rats linearly decreased
both serum MDA concentrations (Table 2; P < 0.0001).
Significant dietary calorie level by CDB level interaction
effect revealed that serum MDA concentration decreased
to a greater extent in the control rats than the HFD rats as
CDB complex level increased (P < 0.0001).
Serum and brain serotonin were greater for rats fed the
control diet than for rats fed the high-fat diet (P < 0.0001).
CDB complex level linearly increased both serum and brain
serotonin concentration (P < 0.0001). However, dietary
calorie level by CDB complex level interaction effect on
serum and brain serotonin was insignificant (Table 3).
Serum and brain tryptophan was also greater for rats fed
the control diet than for rats fed the HFD (P < 0.0001).
CDB complex level linearly increased both serum and
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Table 2. Effects of dietary calorie and CDB complex levels (0 mg/kg BW; 11 mg/kg BW; 22 mg/kg BW) on body weight and various
biochemical parameters.

Variable

Control diet

High-fat diet

CDB dosage, mg/kg BW

CDB dosage, mg/kg BW

0

11

22

0

11

22

SEM

Calorie CDB level

Calorie ×
CDB level

Body weight, g

275.8

276.4

278.1

316.1

302.2

301.7

4.8

0.0001

0.33

0.19

Glucose, mg/dL1

99.4

92.6

86.8

129.4

114.9

107.8

1.2

0.0001

0.0001

0.001

Insulin, pmol/L

37.4

40.2

42.6

40.2

45.1

47.1

0.4

0.0001

0.0001

0.05

1

2.66

2.30

2.04

3.22

2.54

2.29

0.04

0.0001

0.0001

0.001

CISI, mg/dL1

2.67

2.75

2.87

1.56

1.68

1.73

0.01

0.0001

0.0001

0.0001

TC, mg/dL

1

55.5

49.1

42.8

111.6

72.5

68.2

1.4

0.0001

0.0001

0.0001

TG, mg/dL1

46.5

36.4

34.5

104.0

74.0

63.2

5.6

0.0001

0.0001

0.04

1.40

0.90

0.61

3.20

2.10

1.71

0.09

0.0001

0.0001

0.0007

0.84

0.65

0.56

1.71

1.24

0.91

0.04

0.0001

0.0001

0.0001

Glu:Ins

1

FFA, mmol/L

1

Serum MDA, µg/mL1

CDB: Nutritional supplement contains chromium picolinate (CrPic), phosphatidylserine (PS), docosahexaenoic acid (DHA), and
boron; (B). 0: Rats were fed a standard diet and did not receive CDB; 11: rats received 11 mg of CDB complex; 22: rats received 22 mg
of CDB complex; CISI = Composite of Insulin Sensitivity Index; TC = total cholesterol; TG = triglycerides; FFA = free fatty acids; MDA
= malondialdehyde.
Data are expressed as mean ± SE of 10 rats from each group.
1
Linear CDB level effect, P < 0.0001.
Table 3. Effects of dietary calorie and CDB complex levels (0 mg/kg BW; 11 mg/kg BW; 22 mg/kg BW) on serum and brain serotonin
and tryptophan levels.

Variable

Serum serotonin, µg/g

1

Brain serotonin, µg/g1
Serum tryptophan, µg/g
Brain tryptophan, µg/g1

1

Control diet

High-fat diet

CDB dosage, mg/kg BW

CDB dosage, mg/kg BW

0

11

22

0

11

22

222.4

232.2

237.4

200.6

211.9

629.6

644.5

655.2

559.4

582.0

24.6

25.8

27.2

20.7

7.60

8.39

8.95

4.90

SEM

Calorie

CDB level

Calorie ×
CDB level

217.7

1.4

0.0001

0.0001

0.76

594.5

2.6

0.0001

0.0001

0.66

22.0

23.2

0.2

0.0001

0.0001

0.88

5.99

6.66

0.14

0.0001

0.0001

0.34

CDB: Nutritional supplement contains chromium picolinate (CrPic), phosphatidylserine (PS), docosahexaenoic acid (DHA), and
boron; (B). 0: Rats were fed a standard diet and did not receive CDB; 11: rats received 11 mg of CDB complex; 22: rats received 22 mg
of CDB complex.
Data are expressed as mean ± SE of 10 rats from each group.
1
Linear CDB level effect, P < 0.0001.

brain tryptophan concentrations (P < 0.0001). However,
dietary calorie level by CDB level interaction effect on both
serum and brain tryptophan was insignificant (Table 3).
Serum, liver, kidney, and brain Cr concentrations were
greater for rats fed the control diet than for rats fed the
HFD (P < 0.0001). CDB complex level resulted in a linear
increase in serum but quadratic increases in liver, kidney,

and brain Cr concentrations (P < 0.0001). Dietary calorie
level by CDB complex level interaction effect on serum Cr
was insignificant. However, dietary calorie level by CDB
complex level interaction effects revealed that liver Cr
level linearly increased in rats fed the HFD diet, whereas
it increased quadratically in rats fed the control diet (P
< 0.006). Elevations in kidney and brain Cr levels in the
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control rats were more notable than in the HFD group as
dietary CDB complex level increased (P ≤ 0.02) (Table 4).
The spatial memory acquisition responses upon
treatments are given in Table 5. Latency was lower but
probe was greater for rats fed the control diet than for rats
fed the HFD (P < 0.05, P < 0.0001, respectively). Increasing
CDB complex levels resulted in a linear decrease in latency
(P < 0.0001) but a linear increase in probe (P < 0.0002).
However, dietary calorie level by CDB complex level
interaction effect on latency and probe was insignificant.
The decrease in latency over time (41.2 on day 1 to 8.9
on day 5; P < 0.0001; Figure) was independent of dietary
calorie level and CDB level.

content, feeding a HFD was expected to promote live
weight gain. Chung et al. (27) found that Sprague-Dawley
rats fed a HFD (3.85 kcal/kg energy) compared with rats
fed a standard diet (4.65 kcal/kg energy) for 4 weeks had
an increase in weight gain. Sahin et al. (28) also found
that rats fed a HFD for 12 weeks had greater body weights
compared with rats fed a regular diet. Results similar to
those of the present work in rodents fed a HFD in an ad
libitum model have also been reported (29). Although the
presence of the CDB complex in the diet changed several
parameters related to energy (carbohydrate and lipid)
metabolism reported in the present work, the inclusion of
the CDB complex in the diet unexpectedly did not have
any influences on the body weight of rats.
Recommended dietary fat intake serves a number
of essential body functions; however, HFDs often lead
to excessive energy intake and are positively associated

4. Discussion
The consumption of a HFD resulted in greater weight gain
compared with the control diet. Due to its high-calorie

Table 4. Effects of dietary calorie and CDB complex levels (0 mg/kg BW; 11 mg/kg BW; 22 mg/kg BW) on the serum and tissue
chromium concentrations.

Variable
Serum Cr, µg/g

1

Liver Cr, mg/kg2
Kidney Cr, mg/kg
Brain Cr, ng/g

2

2

Control diet

High-fat diet

CDB dosage, mg/kg BW

CDB dosage, mg/kg BW

0

11

22

0

11

22

0.016

0.027

0.027

0.012

0.021

0.021

0.030

0.028

0.016

0.020

0.023

0.030

0.030

0.017

17.0

25.6

25.4

11.2

SEM

Calorie

CDB level

Calorie ×
CDB level

0.021

0.001

0.0001

0.0001

0.17

0.021

0.001

0.0001

0.0001

0.006

0.021

0.021

0.001

0.0001

0.0001

0.02

14.9

14.8

0.4

0.0001

0.0001

0.0001

CDB: Nutritional supplement contains chromium picolinate (CrPic), phosphatidylserine (PS), docosahexaenoic acid (DHA), and
boron; (B). 0: Rats were fed a standard diet and did not receive CDB; 11: rats received 11 mg of CDB complex; 22: rats received 22 mg
of CDB complex.
Data are expressed as mean ± SE of 10 rats from each group.
1
Linear CDB level effect, P < 0.0001.
2
Quadratic AMF level effect, P < 0.0001.
Table 5. Effects of dietary calorie and CDB complex levels (0 mg/kg BW; 11 mg/kg BW; 22 mg/kg BW) on latency and probe.
Control Diet
Variable
Latency
Probe2

1,2

HFD
SEM

Calorie

CDB level

Calorie ×
CDB level

16.5

2.4

0.05

0.0001

0.90

27.5

16

0.0001

0.0002

0.82

CDB dosage, mg/kg BW

CDB dosage, mg/kg BW

0

11

22

0

11

22

26.6

15.5

13.4

32.0

19.6

29.8

35.2

37.2

18.8

26.2

CDB: Nutritional supplement contains chromium picolinate (CrPic), phosphatidylserine (PS), docosahexaenoic acid (DHA), and
boron; (B). 0: Rats were fed a standard diet and did not receive CDB; 11: rats received 11 mg of CDB complex; 22: rats received 22 mg
of CDB complex.
Data are expressed as mean ± SE of 10 rats from each group.
1
Time effect, P < 0.0001.
2
Linear CDB level effect, P < 0.0001.
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Figure. Latency to find the hidden platform from the first day
to the fifth day in the Morris water maze task in rats. Time effect
was P < 0.0001.

with impairments in blood glucose regulation, lipid
metabolism (30), and cognitive function (1). As expected,
the HFD of the present work negatively influenced glucose
metabolism by elevating blood glucose, insulin, and
glucose:insulin ratios while decreasing CISI score, and
also lipid metabolism by increasing TC, TG, and FFA
concentrations. The presence of the CDB complex with a
dose response ameliorated the negative effects of feeding
the HFD, in particular when measured as glucose and lipid
metabolism parameters. The effect of the CDB complex
might have been due mostly to the Cr content of the
combination. Sahin et al. (5) reported that feeding a HFD
to diabetic rats increased serum glucose, total cholesterol,
triglycerides, and FFA levels, but supplementary CrPic
in the diet lowered these values. Pattar et al. (31) also
indicated a novel effect of CrPic on cholesterol homeostasis
and a blood glucose-lowering effect by altering the plasma
membrane composition of cholesterol in fat and muscle
cells. The positive (regulatory) effects of CrPic on serum
lipid and carbohydrate values in rats have also been shown
by other investigators (32,33). Supplementation of CrPic
was reported to enhance insulin sensitivity and glucose
disappearance and to improve lipids (total and HDL
cholesterol) in obese male hyperinsulinemic rats (34). In
addition, Krol and Kreipcio (35) reported that another
chromium complex (chromium propionate) fed to
diabetic rats for 5 weeks resulted in significant antidiabetic
(insulin-sensitizing and hypolipidemic) potential and also
reduced serum levels of triacylglycerols and total and LDL
cholesterols. Padmavathi et al. (36) found that chronic
maternal Cr restriction increased body adiposity in rat
offspring and that might predispose them to obesity and
associated diseases in later life.
The findings of glucose and lipid metabolism
parameters could have been not only due to Cr picolinate
but also DHA, PS, and B effects as well. Feeding Sprague-

Dawley rats a DHA-rich diet for 9 weeks resulted in a
decrease in blood triacylglycerols and total cholesterol
concentrations and the intake of DHA is important for brain
phospholipid DHA enrichment and brain NOS activity
(37). Phosphatidylserine, a phospholipid component of
cell membranes, functions in memory and cognition and
has important roles in sports nutrition including hormone
balance for athletes (38). Previous studies reported that
physiologic amounts of boron in rats and cockerels may
help reduce the amount of insulin required to maintain
plasma glucose (39,40). All mentioned works (37–41) are
in agreement with those of present results.
Serum and kidney, liver, and brain Cr concentrations
decreased with feeding of the HFD diet, but the presence
of the CDB complex containing Cr increased the Cr
concentrations of these tissues. These results were expected
as Cr supplements, by nature, accumulate in tissues for
extended periods (42). The present work also showed
that feeding a HFD depresses tissue Cr concentrations.
Similar results were reported in type 2 diabetic mice
(43). On the other hand, it was shown that poststroke
hyperglycemia was accompanied by decreased tissue and
circulating levels of chromium and increased urinary
excretion level of chromium. However, daily chromium
supplementation increased tissue chromium levels,
attenuated brain infarction, improved hyperglycemia, and
decreased plasma levels of glucagon and corticosterone in
stroke rats (44). In another study, it was also reported that
supplementation with chromium-containing milk powder
for 3 weeks elevated serum chromium level and improved
insulin resistance in obese mice (45).
Oxidative stress marker measured as MDA was greater
in rats fed a HFD compared with rats fed a regular diet.
Supplementing the CDB complex to both the high-fat
and regular diet reduced the MDA concentrations. This
is practically more important in the case of HFD feeding.
In accord with the findings of the present work, Preuss et
al. (46) found a decrease in hepatic TBARS formation in
rats supplemented with CrPic or chromium nicotinate. A
relation between free radical production and high lipid
intake leads to oxidative stress, which is obvious from
the increased lipid peroxidation levels in the serum and
liver of rats fed the HFD in the present work. It has been
reported that postprandial oxidative stress is caused by
feeding an energy-dense, fatty meal and serum, liver,
and heart MDA levels are increased by oxidative stress in
HFD-fed rats (47,48). Although the known pathogenic
mechanism of obesity with multiple etiologies remains
obscure, experimental evidence indicates that ROS play
an important role in the pathogenesis of obesity (49,50).
Lupachyk et al. (51) also found that hypertriglyceridemia
and/or increased nonesterified fatty acid concentrations
cause prediabetic neuropathy through oxidative-
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nitrosative stress. The results of the present work could
have been not only due to Cr but also other components of
the CDB complex. Similar to results of the present work,
dietary supplementation of DHA and PS reduced ROS
in the brain tissues of normal mice by 57% (15). Pan et
al. (52) also reported that daily administration of DHA
increased antioxidant enzyme activities and decreased
MDA production in the brain.
Since serotonin is biochemically synthesized from
tryptophan, serotonin and tryptophan were evaluated
together in the present work. Serotonin and tryptophan
levels were both lower in rats fed with HFD, and
supplementing the CDB complex increased both serum
and brain concentrations. Increases in serum and brain
serotonin concentrations were paralleled to increases
in serum and brain tryptophan concentrations. Similar
to results of the present work, the synthesis of brain
serotonin was reported to directly depend on the plasma
concentration of its precursor, tryptophan (53). Serotonin
is known for its feed intake depression effects and thus is
an important factor in preventing obesity (54). Although
not measured in the present work, feed intake could have
been depressed, resulting in lower body weights for rats.
In addition, serotonin reuptake transporter-deficient mice
have been reported to exhibit hyperinsulinemia prior to the
development of obesity. Feeding HFD to rats of the present
work resulted in decreases in serotonin concentrations, in
agreement with the work of Kirac et al. (55), who found
that feeding a HFD to rats for 4 weeks differentially
affected the stress response of striatal dopaminergic and
serotonergic neurons in the brain, influencing motor
activity performance.
Studies of the effects of CrPic, PS, DHA, and boron on
tryptophan and brain serotonin concentration in both rats
and humans with HFDs are limited. However, an animal
study suggested that CrPic supplementation may alter
5-HT neuroendocrine function via increasing peripheral
and central tryptophan availability and elevating brain
serotonin synthesis from tryptophan (56). Khanam and
Pillai (57) also found that CrPic increases serotonergic
transmission in the brain of rats. Additionally, Dubey et al.
(58) reported that CrPic increased serotonin concentration
in the brain.
DHA is a major lipid component of the central nervous
system, accounting for 30%–50% of the total fatty acid
content of the human brain (59). Phosphatidylserine
enhances the availability of acetylcholine and thus is
proven useful in clinical trials of patients with cognitive
impairment (60). Deficits in brain function have most
probably been linked to dietary DHA and PS deficiencies.
Overall, supplementing the CDB complex could have
collectively contributed to the results of the present work.
Latency in the present work was greater in rats fed
the HFD, indicating that feeding a high-fat diet impairs
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hippocampal-dependent memory in rats. However,
even in the HFD, supplementing the CDB complex to
the diets of the rats improved cognitive performance by
reducing latency to find the platform. That means that
supplementing the CDB complex to the diets supported
rats in quickly learning to swim to the correct location with
decreasing escape latencies and more direct swim paths.
Although gradually declining escape latency was expected
over time, CDB complex supplementation hastens the
process. In an opposite way in accord with the latency
results, probe was lower with the HFD. This result implies
that feeding the HFD impairs retention performance in a
spatial water maze probe test. In addition, supplementing
the CDB complex to both HFD and regular diets resulted
in increases in probe. This result implies that the rats
supplemented with CDB complex, even those on the HFD,
swam to the target quadrant of the pool and repeatedly
across the former location of the platform until starting
to search elsewhere. This spatial bias constitutes evidence
for spatial memory. Similar to the results of the present
work, Sahin et al. (28) also found that rats fed a HFD
for 12 weeks had a 27% reduction in mean percentage
time spent in the target quadrant and a 38% increase in
spatial memory acquisition phase compared with rats fed
a regular diet. In the same work (28), supplementing Cr
(CrGly) to rats fed a HFD alleviated memory acquisition.
Learning and memory are related to metabolic diseases.
Similar to results of the present work, individuals with
diabetes have been reported to perform less well on
measures of learning and memory when compared with
nondiabetics (61,62). Those cognitive deficits could be
prevented by insulin treatment in type 1 diabetes mellitus
(63). As proven with the results of the present work,
antidiabetic effects of the CDB complex might have a role
in reversing such deficits. The results of latency and probe
could have been not only due to Cr but also the other
ingredients of the CDB complex supplemented. Similarly,
in a previous study, it was reported that feeding with
DHA and/or PS supplementation not only significantly
improved escape latency of animals but also improved the
oxidative parameters in the brain, enhanced glutathione
peroxidase activity, and reduced nitric monoxide levels in
the livers of rats (64). Additionally, Liu et al. (65) indicated
that DHA and PS extended the escape latency, reversed the
oxidative parameters observed in the brain, and enhanced
SOD activity in the liver of PTZ-induced epileptic
rats. Chung et al. (66) in a work with rats reported that
DHA is critical for the development and maintenance of
learning memory performance. In another study, Chang
et al. (67) showed that DHA exhibited neuroprotective
and antiinflammatory effects against ischemic brain injury
and these effects were accompanied by decreased oxidative
stress and JNK/AP-1 signaling as well as enhanced
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Nrf2/HO-1 expression. Hegsted et al. (68) stated that
rats consuming a low-boron diet could have a negative
influence on brain functions. A work in humans indicated
that inadequate dietary boron resulted in lower frequency
activity in electroencephalograms, as well as less favorable
performance in cognitive and motor tests (69).
Findings of the present work indicated that the CDB
complex with the main ingredient as CrPic along with
phosphatidylserine, docosahexaenoic acid, and boron
plays a crucial health-benefiting role in glucose and lipid
metabolism. Cr is likely to have a proportionally greater
role in these effects. The benefits of the product in most
of the carbohydrate and lipid metabolism parameters
are more pronounced in rats fed the HFD. In addition,
the CDB complex was effective in reducing oxidative
stress and improving neurological functions, such as

learning and memory errors. The CDB complex could
be an alternative treatment for preventing metabolic
diseases and for promoting neuroprotection memories
in individuals having metabolic diseases such as diabetes.
However, further research should be conducted for a
complete understanding of the product, including dose
and side effects.
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